Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New product for anemia in hemodialysis patients now available in U.S.

June 22, 1999

NN-304 is a safe and predictable insulin analogue in human studies

June 22, 1999

New insulin preparation with improved stability for delivery via implanted pump

June 22, 1999

News from ADA: antidiabetic efficacy of the ingredients of an animal prostate extract

June 22, 1999

Role of pyruvate dehydrogenase in diabetes

June 22, 1999

Ipamorelin exerts potent GH secretagogue activity in pig fetuses

June 21, 1999

ENDO '99: steroid mimetic agent with selective anabolic effects on osteoblasts from RWJ

June 21, 1999

New therapeutic strategy presented at ADA: dipeptidyl peptidase IV inhibitors

June 21, 1999

New antidiabetic agent presented by Bayer scientists this week in San Diego

June 21, 1999

Trimegestone is potentially superior to MPA for HRT

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...